Home > Share Market > Stocks > Balaxi Pharmaceuticals Ltd > Financial Statements > BALAXI Cash Flow

Balaxi Pharmaceuticals Ltd Financial Statements

Balaxi Pharmaceuticals Ltd Cash Flow Statement

  • Tabular Data
  • Graph
Y/e 31 Mar ( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2019
Profit before tax 54.50 44.30 8.87 2.44
Depreciation (0.50) (0.30) -- --
Tax paid (6.90) (6.20) (2.80) (0.50)
Working capital 78.20 36.10 (36) --
Other operating items -- -- -- --
Operating cashflow 125 73.90 (30) --
Capital expenditure 29.20 2.55 (2.60) --
Free cash flow 155 76.50 (33) --
Equity raised 62.90 34.60 66.60 --
Investments -- 3.42 (3.40) --
Debt financing/disposal 3.64 3.66 3.66 --
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash 221 118 34.30 --

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000